Publications of the last 5 years

Here is a list of publications of the team over the last 5 years, for all the data you can view the output page.

Refereed articles (rank A)

  1. Belaroussi, R. ; Ejjoummany, A. ; El Hakmaoui, A. ; Akssira, M. ; Guillaumet, G. ; Routier, S.
    Three successive and regiocontroled palladium cross-coupling reactions to easily synthesize novel series of 2,4,6-tris(het)aryl pyrido[1′,2′:1,5]pyrazolo[3,4-d]pyrimidines
    RSC Advances 2018, 8, 732-741.
    Impact Factor: 3.108

  2. Laugeray, A. ; Oummadi, A. ; Jourdain, C. ; Feat, J. ; Meyer-Dilhet, G. ; Menuet, A. ; Plé, K. ; Gay, M. ; Routier, S. ; Mortaud, S. ; Guillemin, G. J.
    Perinatal exposure to the cyanotoxin β-N-Methylamino-L-alanine (BMAA) results in long-lasting behavioral changes in offspring-potential involvement of DNA damage and oxidative stress
    Neurotox. Res. 2018, 33, 87-112.
    Impact Factor: 2.942

  3. Burban, A. ; Sharanek, A. ; Hue, R. ; Gay, M. ; Routier, S. ; Guillouzo, A. ; Guguen-Guillouzo, C.
    Penicillinase-resistant antibiotics induce non-immune-mediated cholestasis through HSP27 activation associated with PKC/P38 and PI3K/AKT signaling pathways
    Sci. Rep. 2017, 7, 1815.
    Impact Factor: 5.228

  4. Constantin, S. ; Lupascu, F. G. ; Apotrosoasei, M. ; Vasincu, I. M. ; Lupascu, D. ; Buron, F. ; Routier, S. ; Profire, L.
    Synthesis and biological evaluation of the new 1,3-dimethylxanthine derivatives with thiazolidine-4-one scaffold
    Chemistry Central Journal 2017, 11:12, .
    Impact Factor: 2.55

  5. D'Attoma, J. ; Camara, T. ; Brun, P. L. ; Robin, Y. ; Bostyn, S. ; Buron, F. ; Routier, S.
    Efficient transposition of the Sandmeyer reaction from batch to continuous process
    Org. Process Res. Dev. 2017, 21, 44-51.
    Impact Factor: 2.922

  6. Desplat, V. ; Vincenzi, M. ; Lucas, R. ; Moreau, S. ; Savrimoutou, S. ; Rubio, S. ; Pinaud, N. ; Bigat, D. ; Enriquez, E. ; Marchivie, M. ; Routier, S. ; Sonnet, P. ; Rossi, F. ; Ronga, L. ; Guillon, J.
    Synthesis and antiproliferative effect of Ethyl 4-[4-(4-substituted piperidin-1-yl)]benzylpyrrolo[1,2-a]quinoxalinecarboxylate derivatives on Human Leukemia Cells
    ChemMedChem 2017, 12, 940-953.
    Impact Factor: 3.225

  7. Foucault-Fruchard, L. ; Doméné, A. ; Page, G. ; Windsor, M. ; Emond, P. ; Rodrigues, N. ; Dolle, F. ; Damont, A. ; Buron, F. ; Routier, S. ; Chalon, S. ; Antier, D.
    Neuroprotective effect of the alpha 7 nicotinic receptor agonist PHA 543613 in an in-vivo excitotoxic adult rat model
    Neuroscience 2017, 356, 52-63.
    Impact Factor: 3.42

  8. Ledru, H. ; D'Attoma, J. ; Bostyn, S. ; Routier, S. ; Buron, F. ; Lopin-Bon, C.
    Screening of activation tools to design sulfated saccharides
    ChemistrySelect 2017, 2, 9637-9641.
    Impact Factor:

  9. Nicolas, C. ; Cocaud, C. ; Maujoin, A. ; Zheng, R. B. ; Lowary, T. L. ; Rodrigues, N. ; Percina, N. ; Chartier, A. ; Buron, F. ; Routier, S. ; Martin, O. R.
    Triazole-linked iminosugars and aromatic systems as simplified UDP-Galf mimics: synthesis and preliminary evaluation as Galf-transferase inhibitors
    Eur. J. Org. Chem. 2017, 6192–6201.
    Impact Factor: 2.834

  10. Place, M. ; Copin, C. ; Apotrosoasei, M. ; Constantin, S. ; Vasincu, I. M. ; Profire, L. ; Buron, F. ; Routier, S.
    Synthesis of [1,3,4]thiadiazolo[3',2':1,2]imidazo[4,5-c]quinolines including Pictet-Spengler reaction and exploration of their C-2 reactivity through SNAr
    J. Org. Chem. 2017, 82, 13700-13707.
    Impact Factor: 4.849

  11. Belaroussi, R. ; El Hakmaoui, A. ; Akssira, M. ; Guillaumet, G. ; Routier, S.
    Regioselective Synthesis of 2,4-Substituted Pyrido[1′,2′:1,5]pyrazolo[3,4-d]pyrimidines through Sequential Pd-Catalyzed Arylation and SNAr Reactions
    Eur. J. Org. Chem. 2016, 3550-3558.
    Impact Factor: 2.834

  12. Champiré, A. ; Vala, C. ; Laabid, A. ; Benharref, A. ; Marchivie, M. ; Plé, K. ; Routier, S.
    Controlled Dimroth rearrangement in the Suzuki-Miyaura cross coupling of triazolopyridopyrimidines
    J. Org. Chem. 2016, 81, 12506-12513.
    Impact Factor: 4.785

  13. Constantin, S. ; Buron, F. ; Routier, S. ; Confederat, L. ; Teodora Pânzariu, A. ; Miron, A. ; Profire, L.
    Studies on xanthine derivatives (ii). Synthesis and antioxidant effects of some hydrazones with xanthine structure
    Farmacia 2016, 64, 565-571.
    Impact Factor: 1.162

  14. Copin, C. ; Henry, N. ; Buron, F. ; Routier, S.
    Palladium-catalyzed direct arylation of 2,6-disubstituted imidazo[2,1-b][1,3,4]thiadiazoles
    Synlett 2016, 27, 1091-1095.
    Impact Factor: 2.419

  15. Copin, C. ; Buron, F. ; Routier, S.
    Palladium-catalyzed amination of C-5 bromoimidazo[2,1-b][1,3,4]thiadiazoles
    Eur. J. Org. Chem. 2016, 1958-1962.
    Impact Factor: 2.834

  16. D'Attoma, J. ; Cozien, G. ; Brun, P. L. ; Robin, Y. ; Bostyn, S. ; Buron, F. ; Routier, S.
    Fast functionalization of (7-aza)indoles using continuous flow processes
    ChemistrySelect 2016, 1, 338-342.
    Impact Factor:

  17. Desplat, V. ; Vincenzi, M. ; Lucas, R. ; Moreau, S. ; Savrimoutou, S. ; Pinaud, N. ; Lesbordes, J. ; Peyrilles, E. ; Marchivie, M. ; Routier, S. ; Sonnet, P. ; Rossi, F. ; Ronga, L. ; Guillon, J.
    Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxy late derivatives in myeloid and lymphoid leukemia cell lines
    Eur. J. Med. Chem. 2016, 113, 214-227.
    Impact Factor: 3.447

  18. Ouach, A. ; Pin, F. ; Bertrand, E. ; Vercouillie, J. ; Gulhan, Z. ; Mothes C. ; Deloye, J.-B. ; Guilloteau, D. ; Suzenet, F. ; Chalon, S. ; Routier, S.
    Design of α7 nicotinic acetylcholine receptor ligands using the (Het)Aryl-1,2,3-triazole core: synthesis, in vitro evaluation and SAR studies
    Eur. J. Med. Chem. 2016, 107, 153-164.
    Impact Factor: 3.447

  19. Ouach, A. ; Boulahjar, R. ; Vala, C. ; Bourg, S. ; Bonnet, P. ; Guguen-Guillouzo, C. ; Ravache, M. ; Le Guével, R. ; Lozach, O. ; Lazar, S. ; Troin, Y. ; Meijer, L. ; Ruchaud, S. ; Akssira, M. ; Guillaumet, G. ; Routier, S.
    Novel optimization of valmerins (tetrahydropyrido[1,2-a]isoindolones) as potent dual CDK5/GSK3 inhibitors
    Eur. J. Med. Chem. 2016, 115, 311-325.
    Impact Factor: 3.447

  20. Pânzariu, A.-T. ; Apotrosoasei, M. ; Vasincu, I. M. ; Drăgan, M. ; Constantin, S. ; Buron, F. ; Routier, S. ; Profire, L. ; Tuchilus, C.
    Synthesis and biological evaluation of new 1,3-thiazolidine-4-one derivatives of nitro-l-arginine methyl ester
    Chemistry Central Journal 2016, 10, 6.
    Impact Factor: 2.19

  21. Rodrigues, N. ; Boiaryna, L. ; Vercouillie, J. ; Guilloteau, D. ; Suzenet, F. ; Buron, F. ; Routier, S.
    Tandem silver-catalyzed cyclization/nucleophilic functionalization of 2-alkynylindole-3-carbaldehyde oximes to afford new 2,4-disubstituted γ-carbolines
    Eur. J. Org. Chem. 2016, 5024-5036.
    Impact Factor: 2.834

  22. Belaroussi, R. ; El Hakmaoui, A. ; Percina, N. ; Chartier, A. ; Marchivie, M. ; Massip, S. ; Jarry, C. ; Akssira, M. ; Guillaumet, G. ; Routier, S.
    Synthesis of 1,4-disubstituted pyrido[1′,2′:1,5]pyrazolo[3,4-d]pyridazines by means of SNAr and palladium-catalysed reactions
    Eur. J. Org. Chem. 2015, 4006-4017.
    Impact Factor: 3.15

  23. Bonnet, C. S. ; Laine, S. ; Buron, F. ; Tircsó, G. ; Pallier, A. ; Helm, L. ; Suzenet, F. ; Tóth, E.
    A pyridine-based ligand with two hydrazine functions for lanthanide chelation: remarkable kinetic inertness for a linear, bishydrated complex
    Inorganic Chemistry 2015, 54, 5991-6003.
    Impact Factor: 4.762

  24. Boulahjar, R. ; Ouach, A. ; Bourg, S. ; Bonnet, P. ; Lozach, O. ; Meijer, L. ; Guguen-Guillouzo, C. ; Le Guével, R. ; Lazar, S. ; Akssira, M. ; Troin, Y. ; Guillaumet, G. ; Routier, S.
    Advances in tetrahydropyrido[1,2-a]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitors
    Eur. J. Med. Chem. 2015, 101, 274-287.
    Impact Factor: 3.447

  25. Buron, F. ; Mérour, J. Y. ; Akssira, M. ; Guillaumet, G. ; Routier, S.
    Recent advances in the chemistry and biology of pyridopyrimidines
    Eur. J. Med. Chem. 2015, 95, 76-95.
    Impact Factor: 3.447

  26. Chalon, S. ; Vercouillie, J. ; Guilloteau, D. ; Suzenet, F. ; Routier, S.
    PET tracers for imaging brain α7 nicotinic receptors: an update
    Chem. Commun. 2015, 51, 14826-14831.
    Impact Factor: 6.834

  27. Copin, C. ; Massip, S. ; Leger, J. M. ; Jarry, C. ; Buron, F. ; Routier, S.
    SNAr versus Buchwald-Hartwig amination/amidation in the imidazo[2,1-b][1,3,4]thiadiazole series
    Eur. J. Org. Chem. 2015, 6932-6942.
    Impact Factor: 3.068

  28. Oukoloff, K. ; Buron, F. ; Routier, S. ; Jean, L. ; Renard, P.-Y.
    Synthetic route to rare isoindolones derivatives
    Eur. J. Org. Chem. 2015, 2450-2456.
    Impact Factor: 3.15

  29. Panzariu, A. ; Mirela, I. ; Vasincu, I. M. ; Dragostin, O. M. ; Dragan, M. ; Buron, F. ; Routier, S. ; Profire, L.
    New arginine derivatives - synthesis and biological evaluation
    Farmacia 2015, 63, 581-585.
    Impact Factor: 1.162

  30. Apotrosoasei, M. ; Vasincu, I. M. ; Dragan, M. ; Buron, F. ; Routier, S. ; Profire, L.
    Design, synthesis and the biological evaluation of New 1,3-thiazolidine-4-ones based on the 4-amino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one scaffold
    Molecules 2014, 19, 13824-13847.
    Impact Factor: 2.416

  31. Ben Othman, R. ; Massip, S. ; Marchivie, M. ; Jarry, C. ; Vercouillie, J. ; Chalon, S. ; Guillaumet, G. ; Suzenet, F. ; Routier, S.
    Sulfur-carbon bond formation through ring-opening of triazolothiadiazole with organometallics
    Eur. J. Org. Chem. 2014, 3225-3231.
    Impact Factor: 3.154

  32. Cheray, M. ; Nadaradjane, A. ; Bonnet, P. ; Routier, S. ; Valette, F. M. ; Cartron, P. F.
    Specific inhibition of DNMT1/CFP1 reduces cancer phenotypes and enhances chemotherapy effectiveness
    Epigenomics 2014, 3, 267-275.
    Impact Factor: 5.215

  33. Dehbi, O. ; Tikad, A. ; Bourg, S. ; Bonnet, P. ; Lozach, O. ; Meijer, L. ; Aadil, M. ; Akssira, M. ; Guillaumet, G. ; Routier, S.
    Synthesis and optimization of an original V-shaped collection of 4-7-disubstituted pyrido[3,2-d]pyrimidines as CDK5 and DYRK1A inhibitors
    Eur. J. Med. Chem. 2014, 80, 352-363.
    Impact Factor: 3.432

  34. Le Meur, M. ; Bourg, S. ; Massip, S. ; Marchivie, M. ; Jarry, C. ; Guillaumet, G. ; Routier, S.
    First palladium-catalyzed direct regioselective C-5 (het)arylation of mono- or disubstituted thiazolo[3,2-b][1,2,4]triazoles
    Eur. J. Org. Chem. 2014, 3704-3714.
    Impact Factor: 3.154

  35. Mérour, J. Y. ; Buron, F. ; Plé, K. ; Bonnet, P. ; Routier, S.
    The azaindole framework in the design of kinase inhibitors
    Molecules 2014, 19, 19935-19979.
    Impact Factor: 2.416

  36. Nehmé, R. ; Nehmé, H. ; Saurat, T. ; De Tauzia, M. L. ; Buron, F. ; Lafite, P. ; Verrelle, P. ; Chautard, E. ; Morin, Ph. ; Routier, S. ; Bénédetti, H.
    New in-capillary electrophoretic kinase assays to evaluate inhibitors of the PI3k/Akt/mTOR signaling pathway
    Anal. Bioanal. Chem. 2014, 406, 3743-3754.
    Impact Factor: 3.578

  37. Pin, F. ; Vercouillie, J. ; Ouach, A. ; Mavel, S. ; Gulhan, Z. ; Chicheri, G. ; Jarry, C. ; Massip, S. ; Deloye, J.-B. ; Guilloteau, D. ; Suzenet, F. ; Chalon, S. ; Routier, S.
    Design of α7 nicotinic acetylcholine receptor ligands in quinuclidine, tropane and quinazoline series. Chemistry, molecular modeling, radiochemistry, in vitro and in rats evaluations of a [18F] quinuclidine derivative
    Eur. J. Med. Chem. 2014, 83, 214-224.
    Impact Factor: 3.432

  38. Riadi, Y. ; Mamouni, R. ; Routier, S. ; Guillaumet, G. ; Lazar, S.
    Ecofriendly synthesis of 3-cyanopyridine derivatives by multi-component reaction catalyzed by animal bone meal
    Environ. Chem. Lett. 2014, 12, 523-527.
    Impact Factor: 1.906

  39. Saurat, T. ; Buron, F. ; Rodrigues, N. ; De Tauzia, M. L. ; Colliandre, L. ; Bourg, S. ; Bonnet, P. ; Guillaumet, G. ; Akssira, M. ; Corlu, A. ; Guillouzo, C. ; Berthier, P. ; Rio, P. ; Jourdan, M.-L. ; Bénédetti, H. ; Routier, S.
    Design, synthesis, and biological activity of pyridopyrimidine scaffolds as novel PI3K/mTOR dual inhibitors
    J. Med. Chem. 2014, 57, 613-631.
    Impact Factor: 5.48

  40. Vasincu, I. ; Apotrosoasei, M. ; Panzariu, A. ; Buron, F. ; Routier, S. ; Profire, L.
    Synthesis and biological evaluation of new 1,3-thiazolidine-4-one derivatives of 2-(4-isobutylphenyl)propionic acid
    Molecules 2014, 19, 15005-15025.
    Impact Factor: 2.416

  41. Amalric, L. ; Baran, N. ; Coureau, C. ; Maingot, L. ; Buron, F. ; Routier, S.
    Analytical developments for 47 pesticides: first identification of neutral chloroacetanilide derivatives in French groundwater
    International Journal of Environmental Analytical Chemistry 2013, 93, 1660-1675.
    Impact Factor: 1.295

  42. Belaroussi, R. ; El Bouakher, A. ; Marchivie, M. ; Massip, S. ; Jarry, C. ; El Hakmaoui, A. ; Guillaumet, G. ; Routier, S. ; Akssira, M.
    Convenient synthesis of new N-3-substituted pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidine-2,4(1H,3H)-dione derivatives
    Synthesis 2013, 45, 2557-2566.
    Impact Factor: 2.443

  43. Dubernet, M. ; Duguet, N. ; Colliandre, L. ; Berini, C. ; Helleboid, S. ; Bourotte, M. ; Daillet, M. ; Maingot, L. ; Daix, S. ; Delhomel, J.-F. ; Morin-Allory, L. ; Routier, S. ; Walczak, R.
    Identification of new nonsteroidal RORα ligands; Related structure–activity relationships and docking studies
    ACS Med. Chem. Lett. 2013, 4, 504-508.
    Impact Factor: 3.073

  44. Lacerda, S. ; Bonnet, C. S. ; Pallier, A. ; Villette, S. ; Foucher, F. ; Westall, F. ; Buron, F. ; Suzenet, F. ; Petoud, S. ; Petoud, S. ; Tóth, E.
    Lanthanide-based, near-infrared luminescent and magnetic lipoparticles: monitoring particle integrity
    Small 2013, 9, 2662-2666.
    Impact Factor: 7.514

  45. Martins, A. F. ; Morfin, J.-F. ; Kubíčková, A. ; Kubiček, V. ; Buron, F. ; Suzenet, F. ; Salerno, M. ; Lazar, A. N. ; Duyckaerts, C. ; Arlicot, N. ; Guilloteau, D. ; Geraldes, C. F. G. C. ; Tóth, E.
    PiB-Conjugated, metal-based imaging probes: multimodal approaches for the visualization of β-amyloid plaques
    ACS Med. Chem. Lett. 2013, 4, 436-440.
    Impact Factor: 3.073

  46. Mérour, J. Y. ; Routier, S. ; Suzenet, F. ; Joseph, B.
    Recent advances in the synthesis and properties of 4-, 5-,6- or 7-azaindoles
    Tetrahedron 2013, 69, 4767-4834.
    Impact Factor: 2.817

  47. Nehmé, H. ; Nehmé, R. ; Lafite, P. ; Duverger, E. ; Routier, S. ; Morin, Ph.
    Electrophoretically mediated microanalysis for in-capillary electrical cell lysis and fast enzyme quantification by capillary electrophoresis
    Anal. Bioanal. Chem. 2013, 405, 9159-9167.
    Impact Factor: 3.578

  48. Nehmé, H. ; Nehmé, R. ; Lafite, P. ; Routier, S. ; Morin, Ph.
    In-capillary reactant mixing for monitoring glycerol kinase kinetics by CE
    Journal of Separation Science 2013, 36, 2151-2157.
    Impact Factor: 2.594

  49. Nehmé, H. ; Nehmé, R. ; Lafite, P. ; Routier, S. ; Morin, Ph.
    Human protein kinase inhibitor screening by capillary electrophoresis using transverse diffusion of laminar flow profiles for reactant mixing
    J. Chromatogr. A 2013, 1314, 298-305.
    Impact Factor: 4.258

  50. Riadi, Y. ; Abrouki, Y. ; El Antri, S. ; Mamouni, R. ; El Haddad, M. ; Routier, S. ; Guillaumet, G. ; Lazar, S.
    Efficient synthesis of a 2-amino-4H-chromene library by multi-component condensation catalyzed by Animal Bone Meal (ABM) in water
    International Journal of Chemistry 2013, 34, 1152-1156.
    Impact Factor: 5.831

  51. Tikad, A. ; Dehbi, O. ; Akssira, M. ; Aadil, M. ; Massip, S. ; Leger, J. M. ; Jarry, C. ; Guillaumet, G. ; Routier, S.
    Efficient access to 2,7-diarylated pyrido[3,2-d]pyrimidines involving regioselective pallado-dehalogenation and Suzuki cross-coupling reactions
    Synthesis 2013, 45, 491-500.
    Impact Factor: 2.443

the average impact factor is : 3.236



Book Chapter - Book

  1. Buron, F. ; Hiebel, M.-A. ; Mérour, J. Y. ; Plé, K. ; Routier, S.
    Chapter Four - The Chemistry of Sulfur-Containing [5,5]-Fused Ring Systems With a Bridgehead Nitrogen
    Advances in Heterocyclic Chemistry, Scriven, E. F. V.; Ramsden, C. A., Eds. Academic Press 2018, 125, 301-356.

  2. Feizbakhsh, O. ; Place, M. ; Fant, X. ; Buron, F. ; Routier, S. ; Ruchaud, S.
    The mitotic protein kinase haspin and its inhibitors
    Biochemistry, Genetics and Molecular Biology » "Protein Phosphorylation", edited by Claude Prignet 2017, Chap. 2, 31-47.

  3. Serriere, S. ; Doméné, A. ; Vercouillie, J. ; Mothes C. ; Bodard S. ; Rodrigues, N. ; Guilloteau, D. ; Routier, S. ; Page, G. ; Chalon, S.
    Assessment of the protection of dopaminergic neurons by an α7 nicotinic receptor agonist, PHA 543613 using [18F]LBT-999 in a Parkinson’s disease rat model
    Frontiers in Medicine 2017, 8-14.

Refereed articles (rank B)

  1. Constantin, S. ; Vasincu, I. ; Apotrosoasei, M. ; Lupaşcu, F. ; Taușer, G. ; Confederat, L. ; Iacob, A. ; Sava, A. ; Buron, F. ; Routier, S. ; Profire, L.
    Optimization of the synthesis of some new thiazolidine-4-one derivatives with xanthine scaffold
    Rev. Med. Chir. Soc. Med. Nat. Iasi 2017, 121, 438-443.

  2. Iacob, A. ; Drăgan, M. ; Constantin, S. ; Lupaşcu, F. ; Confederat, L. ; Buron, F. ; Routier, S. ; Profire, L.
    Evaluation of antioxidant activity of some imines derivatives of L-arginine
    Rev. Med. Chir. Soc. Med. Nat. Iasi 2016, 120, 439-444.

  3. Constantin, S. ; Panzariu, A. ; Vasincu, I. ; Apotrosoasei, M. ; Confederat, L. ; Buron, F. ; Routier, S. ; Profire, L.
    Synthesis and evaluation of antioxidant activity of some hydrazones with xanthine structure
    Rev. Med. Chir. Soc. Med. Nat. Iasi 2015, 119, 910-916.

  4. Panzariu, A. ; Dragan, M. ; Vasincu, I. ; Dragostin, O. M. ; Lupaşcu, F. ; Constantin, S. ; Buron, F. ; Routier, S. ; Profire, L.
    Schiff bases of L-Lysine: microwave induced synthesis, characterization and biological activity
    Rev. Med. Chir. Soc. Med. Nat. Iasi 2015, 119, 931-937.

  5. Sérrière, S. ; Doméné, A. ; Vercouillie, J. ; Mothes C. ; Bodard S. ; Rodrigues, N. ; Guilloteau, D. ; Routier, S. ; Page, G. ; Chalon, S.
    Assessment of the protection of dopaminergic neurons by an α7 nicotinic receptor agonist, PHA 543613 using [18F]LBT-999 in a Parkinson’s disease rat model
    Frontiers in Medicine 2015, 2, 61.

  6. Apotrosoasei, M. ; Vasincu, I. ; Constantin, S. ; Buron, F. ; Routier, S. ; Profire, L.
    Synthesis, characterization and antioxidant activity of some new thiazolidin-4-one derivatives
    Rev. Med. Chir. Soc. Med. Nat. Iasi 2014, 118, 213-218.

  7. Ben Othman, R. ; Marchivie, M. ; Suzenet, F. ; Routier, S.
    3-[(4-Phenoxyphenyl)sulfanyl]-5-phenyl-1H-1,2,4-triazole
    Acta Cryst. 2014, E70, o622-o623.

  8. Vasincu, I. ; Apotrosoasei, M. ; Panzariu, A. ; Buron, F. ; Routier, S. ; Profire, L.
    Development and optimization of the synthesis of new thiazolidin-4-one derivatives of ibuprofen
    Rev. Med. Chir. Soc. Med. Nat. Iasi 2014, 118, 219-224.

Conference proceedings

  1. Aci-Sèche, S. ; Buron, F. ; Robin, L. ; Suzenet, F. ; Routier, S.
    30ièmes Journées Franco-Belges de Pharmacochimie
    Pharmaceuticals 2016, 9, 73.

  2. Boiaryna, L. ; Rodrigues, N. ; Bertrand, E. ; Ouach, A. ; Pin, F. ; Vercouillie, J. ; Mavel, S. ; Gulhan, Z. ; Chicheri, G. ; Deloye, J.-B. ; Guilloteau, D. ; Suzenet, F. ; Chalon, S. ; Routier, S.
    Design of Novel α7 nAchR Tracers: from Ligand Synthesis to 18F PET Imaging Evaluation 29ièmes Journées Franco-Belges de Pharmacochimie: Meeting Report
    Pharmaceuticals 2015, 8, 763.

  3. D'Attoma, J. ; Cozien, G. ; Brun, P. L. ; Robin, Y. ; Bostyn, S. ; Buron, F. ; Routier, S.
    Continuous-flow synthesis of indole derivatives and reusable supported palladium catalyst to Sonogashira reaction 29ièmes Journées Franco-Belges de Pharmacochimie: Meeting Report
    Pharmaceuticals 2015, 8, 776.

  4. Routier, S.
    Efficient Access to Novel Mono- and Disubstituted Pyrido[3,2-d]pyrimidines - 29ièmes Journées Franco-Belges de Pharmacochimie: Meeting Report
    Pharmaceuticals 2015, 8, 759.

  5. Vercouillie, J. ; Routier, S. ; Chicheri, G. ; Ouach, A. ; Bodard S. ; Suzenet, F. ; Pin, F. ; Mothes C. ; Deloye, J.-B. ; Chalon, S. ; Guilloteau, D.
    Radiosynthesis of [18F]FP321, a novel radiotracer to image alpha 7 by PET
    Journal of Labelled Compounds and Radiopharmaceuticals 2013, 56, S305.